I am definitely disappointed/concerned by the decline in YBGJ's revenues. I was fully expecting to see better or more consistent revenue numbers by now (even though a resurge in pandemic-related issues in 2022 has presented a challenge for a number of China-based companies). The existence of Beijing Bihe Biotechnology is something that continues to puzzle and somewhat concern me. I have not really noticed anything of major significance recently on any of the YBGJ social media accounts (but as I mentioned in my previous post, I may miss things at times).
Despite the negative things I said above, I increased my position in YBGJ with a purchase of 50K shares on August 1 at prices of 10 cents and under. I decided to increase my position after the S-1 filing was finally declared effective on that date. It seems somewhat baffling/ridiculous to me that it has taken the SEC almost 15 months to finally approve this filing. I am aware that there was a very brief period of time (only a few weeks or so in late 2021 I think?) during those 15 months when the SEC refused to let Chinese companies sell any securities until the SEC could form/craft mandatory disclosure guidelines (basically boilerplate risk disclosures) for Chinese companies. But as far as I am aware YBGJ's S-1 filings have always contained whatever disclosures/compliance the SEC has requested. A 15-month wait to get a S-1 filing declared effective seems excessive to me.
I did not notice any changes in the terms of the proposed financing and insider sales:
fixed price at 50 cents. Although there is definitely high-risk involved here, now that the filing is declared effective I find the risk/reward of buying some shares here around the 10-cent level to be interesting.
Recent YBGJ News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 11:01:33 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/13/2023 09:06:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:05:41 PM
FEATURED Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM